APOLLO BEACH, Fla., January 14, 2026 (GLOBE NEWSWIRE) —RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”) a company developing ultra-high-resolution retinal imaging technology, today announced
Zwerling expected to guide the Company to its commercial launch. APOLLO BEACH, Fla., December 8, 2025 (GLOBE NEWSWIRE) —RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the
APOLLO BEACH, Fla., October 16, 2025 (GLOBE NEWSWIRE) —RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), RetinalGenix Technologies Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), a
APOLLO BEACH, Fla., October 1, 2025 (GLOBE NEWSWIRE) —RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring,
APOLLO BEACH, Fla., September 25, 2025 (GLOBE NEWSWIRE) —RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), RetinalGenix Technologies Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), a
Cost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans, PET Scans, and Echocardiograms APOLLO BEACH, Fla., June 27, 2025
Appointment Underscores RetinalGenix’s Commitment to Integrating the Latest Advances in genomics and personalized medicine into its product pipeline APOLLO BEACH, Fla., June 13, 2025 (GLOBE
Company to use facility to further development of RetinalGenix’s therapies for neurodegenerative and retinal diseases APOLLO BEACH, Fla., May 5, 2025 (GLOBE NEWSWIRE) — RetinalGenix
Company will discuss its patented remote monitoring high-resolution retinal imaging system RetinalCam™ and associated biomarker technologies APOLLO BEACH, Fla., March 6, 2025 (GLOBE NEWSWIRE) —
High-Resolution Retinal Imaging Now Using Both Near Infrared And Green Modes APOLLO BEACH, Fla., Feb. 20, 2025 (GLOBE NEWSWIRE) — RetinalGenix Technologies Inc OTCQB:RTGN (“RetinalGenix” or the “Company”),
